Literature DB >> 20031345

Menopause and modifiable coronary heart disease risk factors: a population based study.

N Agrinier1, M Cournot, J Dallongeville, D Arveiler, P Ducimetière, J-B Ruidavets, J Ferrières.   

Abstract

OBJECTIVES: The aim of our study was to determine the effect of the menopause on various coronary heart disease (CHD) risk factors and on the global risk of CHD in a population based sample of women, making the difference between menopause and age related effects. STUDY
DESIGN: The Third French MONICA cross-sectional survey on cardiovascular risk included 1730 randomly selected women, aged 35-64 years, representative from the general population. MAIN OUTCOME MEASURES: Women were defined as post-menopausal (postM; n=696), peri-menopausal (periM; n=183) or pre-menopausal (preM; n=659) based on the date of last menses. Socio-demographic, clinical and biological data were collected. Analyses of variance were used to compare means.
RESULTS: PostM women had significantly higher age-adjusted levels of total cholesterol (6.0mmol/L in postM vs. 5.7mmol/L in preM, p<0.05) and LDL cholesterol (3.9mmol/L vs. 3.6mmol/L, p<0.05). There was no difference in HDL cholesterol or triglyceride levels, glycemia or blood pressure. Further adjustment on body mass index and hormonal treatments did not modify the results. No risk factor was significantly different between periM and postM. However, the Framingham 10-year risk of CHD was higher in postM, as compared with periM (5.1% vs. 5.0%, p<0.05). In postM women, lipids and the Framingham risk were not associated with elapsed time since menopause.
CONCLUSIONS: The CHD risk increases during the sixth decade could be explained not only by estrogen deprivation but also by an effect on lipid profile, which is likely to occur in the peri-menopause period. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031345     DOI: 10.1016/j.maturitas.2009.11.023

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  25 in total

1.  Circulating testosterone and SHBG concentrations are heritable in women: the Framingham Heart Study.

Authors:  A D Coviello; W V Zhuang; K L Lunetta; S Bhasin; J Ulloor; A Zhang; D Karasik; D P Kiel; R S Vasan; J M Murabito
Journal:  J Clin Endocrinol Metab       Date:  2011-07-13       Impact factor: 5.958

2.  Trauma exposure and the subsequent risk of coronary heart disease among mid-aged women.

Authors:  June Lee May-Ling; Deborah Loxton; Deirdre McLaughlin
Journal:  J Behav Med       Date:  2014-06-13

Review 3.  Adverse Changes in Body Composition During the Menopausal Transition and Relation to Cardiovascular Risk: A Contemporary Review.

Authors:  Varna Kodoth; Samantha Scaccia; Brooke Aggarwal
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-06-13

4.  The 60- and 70-kDa heat-shock proteins and their correlation with cardiovascular risk factors in postmenopausal women with metabolic syndrome.

Authors:  Eliana A P Nahas; Jorge Nahas-Neto; Claudio L Orsatti; Ana Paula Tardivo; Gilberto Uemura; Maria Terezinha S Peraçoli; Steven S Witkin
Journal:  Cell Stress Chaperones       Date:  2013-12-11       Impact factor: 3.667

5.  Cardiometabolic risk profiles in pre- versus postmenopausal women with spinal cord injury:: preliminary findings.

Authors:  Hillary Hosier; Suzanne L Groah; Alex V Libin; Emily Tinsley; Patricia Burns; Mark S Nash
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

6.  Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials.

Authors:  Marianne Canonico; Geneviève Plu-Bureau; Mary Jo O'Sullivan; Marcia L Stefanick; Barbara Cochrane; Pierre-Yves Scarabin; Joann E Manson
Journal:  Menopause       Date:  2014-03       Impact factor: 2.953

Review 7.  Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis.

Authors:  Verônica Colpani; Cristina P Baena; Loes Jaspers; Gabriella M van Dijk; Ziba Farajzadegan; Klodian Dhana; Myrte J Tielemans; Trudy Voortman; Rosanne Freak-Poli; Gilson G V Veloso; Rajiv Chowdhury; Maryam Kavousi; Taulant Muka; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2018-03-10       Impact factor: 8.082

8.  Effects of Erxian decoction, a Chinese medicinal formulation, on serum lipid profile in a rat model of menopause.

Authors:  Stephen Cw Sze; Ho-Pan Cheung; Tzi-Bun Ng; Zhang-Jing Zhang; Kam-Lok Wong; Hei-Kiu Wong; Yong-Mei Hu; Christine Mn Yow; Yao Tong
Journal:  Chin Med       Date:  2011-11-02       Impact factor: 5.455

9.  A reversal of decreasing trends in population cholesterol levels in Västerbotten County, Sweden.

Authors:  Nawi Ng; Owe Johnson; Bernt Lindahl; Margareta Norberg
Journal:  Glob Health Action       Date:  2012-03-23       Impact factor: 2.640

10.  Cardiovascular mortality among cancer survivors who developed breast cancer as a second primary malignancy.

Authors:  Chengshi Wang; Kejia Hu; Chuanxu Luo; Lei Deng; Katja Fall; Rulla M Tamimi; Unnur A Valdimarsdóttir; Fang Fang; Donghao Lu
Journal:  Br J Cancer       Date:  2021-09-27       Impact factor: 9.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.